Provided by Tiger Trade Technology Pte. Ltd.

Vor Biopharma Inc.

23.24
-1.8650-7.43%
Pre-market: 23.00-0.2350-1.01%09:02 EDT
Volume:824.87K
Turnover:19.56M
Market Cap:1.37B
PE:2.02
High:24.60
Open:24.47
Low:23.21
Close:25.10
52wk High:49.95
52wk Low:6.50
Shares:59.16M
Float Shares:37.23M
Volume Ratio:1.27
T/O Rate:2.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):11.53
EPS(LYR):-70.5015
ROE:-125.43%
ROA:-21.37%
PB:-6.87
PE(LYR):-0.33

Loading ...

Vor Bio Grants Stock Options for 32,550 Shares, RSUs for 6,900 Shares to New Hires Under Inducement Plan

Reuters
·
Aug 04

RA Capital Healthcare Fund Disposes of 213 Vor Biopharma Shares Worth $4,206.75

Reuters
·
Jul 22

Vor Biopharma Director David Zaccardelli Files Initial Beneficial Ownership Statement

Reuters
·
Jul 10

Vor Biopharma Adds Industry Veteran David Zaccardelli to Board

TIPRANKS
·
Jul 08

Press Release: Vor Bio Appoints David Zaccardelli to Board of Directors

Dow Jones
·
Jul 08

Why Vor Biopharma (VOR) Is Up 27.9% After Broad Russell Index Inclusion And What's Next

Simply Wall St.
·
Jul 06

Vor Bio Grants Inducement Awards to New Hires, Including Options for 71,200 Shares at $18.39

Reuters
·
Jul 03

Vor Bio Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 03

Vor Biopharma shareholders back directors and governance measures

TIPRANKS
·
Jun 13

Vor Biopharma shareholders approved amended 2021 equity incentive plan at annual meeting

Reuters
·
Jun 13

Vor Bio gains boost from telitacicept IgA nephropathy approval

TIPRANKS
·
Jun 09

Vor Bio Partner Drug Earns Regulatory Approval In China For Sjogren's Disease

MT Newswires Live
·
Jun 08

Vor Bio says China NMPA approves telitacicept for Sjögren’s disease

Reuters
·
Jun 08

Vor Bio says telitacicept wins China conditional approval for IgA nephropathy

Reuters
·
Jun 08

Telitacicept Receives Nmpa Conditional Approval for the Treatment of Iga Nephropathy in China

THOMSON REUTERS
·
Jun 08

Vor Biopharma’s Phase 3 Sjögren’s Trial Puts Telitacicept on Investors’ Radar

TIPRANKS
·
Jun 05

Vor Bio grants 61,050 stock options, 12,900 RSUs to new hires under inducement plan

Reuters
·
Jun 02

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 02

Vor Biopharma Price Target Maintained With a $31.00/Share by HC Wainwright & Co.

Dow Jones
·
May 19

Vor Bio price target raised to $18 from $15 at Wedbush

TIPRANKS
·
May 15